Agile Therapeutics Stock Forecast
Recent Agile Therapeutics Stock Price |
|
Agile Therapeutics Stock Forecast Price |
$0.00 |
NA% |
$0.00 |
As of
Recent Agile Therapeutics Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
|
|
|
|
Buy ratings: |
|
|
|
|
Hold ratings: |
|
|
|
|
Sell ratings: |
|
|
|
|
Strong sell ratings: |
|
|
|
|
Average rating: |
|
|
|
|
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
The presented Agile Therapeutics stock forecast (traded under symbol AGRX), for forward-twelve-months price target as shown at the top of this page, gives you the average Agile Therapeutics stock forecast for forward target price for symbol AGRX, across the analysts covering Agile Therapeutics (AGRX), as reported in
data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Agile Therapeutics stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Agile Therapeutics stock forecast and half had a lower Agile Therapeutics stock forecast) was $ as of (which is a different mathematical metric versus taking the average or mean), while the
highest Agile Therapeutics stock forecast in the analyst group was $, and the lowest Agile Therapeutics stock forecast in the analyst group was
$, with a standard deviation of $. Get the latest Zacks research report on AGRX — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
|
April 28, 2024 6:35 PM Eastern
Strong Buy (4.00 out of 4)
100th percentile
|
|